INSIGHTS ON DRUG DEVELOPMENT
-
Easy Automation For Cell-Based Assays
Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
-
Aggregate Analysis Of Semaglutide
Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.
-
Grace Capabilities Update February 2026: AI Drug Development
Discover support for your next small molecule drug substance program and learn how artificial intelligence and machine learning tools can be applied to accelerate API development.
-
Improving Swallowing And Palatability With Patient‑Friendly Forms
Improve medication adherence and health outcomes by developing patient-friendly dosage forms that enhance swallowability and palatability for pediatric, geriatric, and dysphagic populations.
-
API In Capsule Vs. The Lost Art Of Formulation Development11/5/2025
API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
Human Skin Explant Model For The Investigation Of Topical Therapeutics8/4/2025
Learn more about an ex vivo cultured human skin explant model in which pathological tissue integrity, barrier function, and metabolic stability have been characterized over time.
-
Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs2/23/2026
Learn how formulation, processing, and scale‑up choices impact the stability, structure, and performance of semi‑solid topicals while ensuring consistent quality through development.
-
Quantifying Endotoxins Via Absorbance Or Fluorescence3/20/2026
Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.
-
The Global Leader In Organ-On-A-Chip Technology8/2/2024
What are organ chips, and how are they being used to better predict the human body's response to medications, food, and chemicals?
DRUG DEVELOPMENT SOLUTIONS
-
Unlock precision and flexibility in your lab with a microplate reader that features five detection modes, hybrid optics, and advanced environmental controls for complex assay workflows.
-
With high-performance optics and ergonomic design, the Leica DM IL LED is ideal for cell culture, micromanipulation, documentation of immunostained specimens, and routine live cell examinations.
The Leica DM IL LED features a comprehensive set of contrast methods to monitor your specimen the way you need. High-quality Phase contrast, excellent modulation contrast and brilliant fluorescence are just one fingertip away. Robust stability, plenty of space to work with tools, long working distances to accommodate large culture flasks and a stable illumination without heat make work at the microscope easy and convenient.
For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) including in-vitro-fertilization (IVF).
-
Explore our full range of products, each backed by rigorous quality control and regulatory compliance, to find the right solution for your pharmaceutical needs.
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.